NCT00066456View on ClinicalTrials.gov

Radiation Therapy to the Abdomen Plus Docetaxel in Treating Patients With Recurrent or Persistent Advanced Ovarian, Peritoneal, or Fallopian Tube Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

September 30, 2003

Primary Completion Date

July 31, 2010

Conditions
Fallopian Tube CarcinomaPrimary Peritoneal CarcinomaRecurrent Ovarian CarcinomaStage III Ovarian CancerStage IV Ovarian Cancer
Interventions
RADIATION

3-Dimensional Conformal Radiation Therapy

DRUG

Chemosensitization/Potentiation Therapy

DRUG

Docetaxel

Given IV

Trial Locations (7)

40536

University of Kentucky/Markey Cancer Center, Lexington

44060

Lake University Ireland Cancer Center, Mentor

44106

Case Western Reserve University, Cleveland

46202

Indiana University/Melvin and Bren Simon Cancer Center, Indianapolis

52242

University of Iowa/Holden Comprehensive Cancer Center, Iowa City

60637

University of Chicago Comprehensive Cancer Center, Chicago

74104

Cancer Care Associates-Midtown, Tulsa

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Gynecologic Oncology Group

NETWORK

NCT00066456 - Radiation Therapy to the Abdomen Plus Docetaxel in Treating Patients With Recurrent or Persistent Advanced Ovarian, Peritoneal, or Fallopian Tube Cancer | Biotech Hunter | Biotech Hunter